allopurinol
General
Genetic Implications:
Pronunciation:
al-oh-pure-i-nole
![](.//images/locked-audio.png)
Trade Name(s)
- Aloprim
- Zyloprim
Ther. Class.
antigout agents
antihyperuricemics
Pharm. Class.
xanthine oxidase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Allopurinol." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51025/11.0/repview.
Vallerand AHA, Sanoski CAC, Quiring CC. Allopurinol. Davis's Drug Guide. F.A. Davis Company; 2023. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51025/11.0/repview. Accessed June 6, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Allopurinol. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51025/11.0/repview
Vallerand AHA, Sanoski CAC, Quiring CC. Allopurinol [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 June 06]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51025/11.0/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - allopurinol
ID - 51025
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51025/11.0/repview
PB - F.A. Davis Company
ET - 18
DB - Pediatrics Central
DP - Unbound Medicine
ER -